Pathos AI collects $365M to fuel data-driven oncology studies
Pathos AI, seeking to upend cancer drug development with artificial intelligence and large multimodal models, has raised the third-largest private funding round in biotech so far this year. In the industry's 25th megaround of 2025 ...
